Glugon 1mg Injection contains Glucagon, a peptide hormone used primarily for the emergency treatment of severe hypoglycemia in diabetic patients when oral glucose administration is not feasible. Glucagon acts by stimulating hepatic glycogenolysis, leading to an increase in blood glucose levels. This injection is indicated for patients experiencing hypoglycemic episodes characterized by unconsciousness or inability to swallow. Additionally, Glugon may be employed as a diagnostic aid in radiology to relax smooth muscles of the gastrointestinal tract. The recommended dose for adults and children over 25 kg is 1 mg administered via intramuscular, subcutaneous, or intravenous injection, with the intravenous route preferred for rapid effect. In cases of hypoglycemia, if the patient does not respond within 15 minutes, a second dose may be administered. It is essential to follow up with oral carbohydrate intake once the patient regains consciousness to replenish glycogen stores. Glugon should be used cautiously in patients with insulinoma or pheochromocytoma due to the risk of adverse cardiovascular effects. Common side effects include nausea, vomiting, and hypersensitivity reactions. Proper medical supervision is advised during administration to monitor patient response and manage potential complications.